Our AdComm Transcripts service provides you a documentation of the meeting within 3-5 business days after the proceedings.
In order to expedite the service it is important to request this service in advance. The FDA provides transcripts of meetings for free 4-8 weeks after a meeting. Our service is for those that need this text media quickly.
- Oncologic Drugs AdComm
Meeting Date: 7/9/15-7/9/15
The committee will discuss biologics license application 125547, necitumumab injection, application submitted by Eli Lilly and Company. The proposed indication (use) for this product is in combination with gemcitabine and cisplatin for first-line treatment of patients with locally advanced or metastatic squamous non-small cell lung cancer.
|Location:||FDA Meeting Room||Related News Links:||Not Available|